Class / Patent application number | Description | Number of patent applications / Date published |
424686000 | Carbonate or bicarbonate | 45 |
20100098781 | CARBONATE RADICAL-CONTAINING MAGNESIUM HYDROXIDE PARTICLE AND MANUFACTURING METHOD THEREOF - A magnesium hydroxide particle having a BET specific surface area of 80 m | 04-22-2010 |
20110206779 | GASTRIC ULCER THERAPEUTIC AGENT - A gastric ulcer therapeutic agent comprising as an active ingredient a composite hydroxide of a hydrotalcite and an aluminum hydroxide compound, which composite hydroxide is represented by the formula (1), | 08-25-2011 |
20120040023 | Use of Date Syrup as a Binder - This invention is concerned with the use of date syrup used as a binder (agglutinant) for solid dosage forms, such as tablets. The features of the granules and the tablets have been studied in comparison with granules and tablets which use different types of agglutinants such as starch paste and sucrose syrup and the results have shown that the use of date syrup as a binder for tablets yields results superior to other kinds of binders. In addition, date syrups gives the granules and tablets a fair color, good taste, distinct and pleasant odor, and it is favorable in regards to shape and taste by patients. | 02-16-2012 |
20120064179 | BICARBONATE SOLUTION FOR BIOAVAILABLE MAGNESIUM AND USES THEREOF - The invention relates to a method of prevention or treatment of a condition such as magnesium deficiency or deficit or abnormality, creatine or creatine phosphate (phosphocreatine) deficiency or abnormality, parathyroid hormone (PTH) excess or abnormality, sodium deficiency or abnormality, potassium deficiency or abnormality, antidiuretic hormone excess or abnormality or a condition characterised by abnormal levels of parathyroid hormone related protein (PTHrP). In the method, a therapeutic quantity of a neutral to mildly alkaline solution of a magnesium salt comprising bicarbonate ions is administered to the patient. | 03-15-2012 |
20120288573 | USE OF EXTRACTS FROM SALONUM GLAUCOPHYLLUM FOR TREATING BONE METABOLISM DISORDERS AND KIDNEY DISORDERS - A method is provided for preventing or treating bone or musculoskeletal metabolism disorders or kidney malfunction in humans. It comprises providing to a subject in need of that a calcium containing or calcium enriched diet combined with the administration of an efficient amount of a plant extract of | 11-15-2012 |
20130071493 | Dietary supplement containing alkaline electrolyte butters - An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would limit the effectiveness of the agent and a sufficient amount of an alkaline electrolyte additive is provided in combination with the agent to raise the pH of the composition to a level of from about 8 to about 12.5 to increase the effectiveness and functional utilization of the agent while the composition is in the person's stomach. In a preferred composition, the electrolyte additive is selected from the group consisting of calcium, magnesium and potassium electrolytes. The supplement composition may be in the form of tablet, capsule, powder or liquid forms. The supplement composition is designed to provide for optimum utilization of a dietary and/or therapeutic supplement agent when taken orally with food or a beverage. | 03-21-2013 |
20150010652 | HYDROTALCITE FINE PARTICLES - Hydrotalcite particles having an extremely small average secondary particle diameter and a production process therefor. A resin composition comprising hydrotalcite fine particles and having excellent transparency and a molded article thereof. | 01-08-2015 |
424687000 | Calcium carbonate | 38 |
20080199540 | Orally-administrable compositions comprising stable amorphous calcium carbonate - The present invention provides orally-administrable compositions comprising stable amorphous calcium carbonate (ACC). The compositions are preferably prepared as solid dosage forms such as tablets, capsules and powders. The present invention further provides methods for supplementing oral calcium intake in subjects and as well as methods for treating osteoporosis, osteomalacia and related diseases. | 08-21-2008 |
20080248136 | ACUTE AND CHRONIC HEARTBURN COMPOSITION AND METHOD - The present invention relates to a composition and method for the simultaneous alleviation of the symptoms form both acute and chronic gastric and esophageal reflux disorder. The composition of the present invention comprises at least calcium carbonate, aluminum hydroxide, or magnesium hydroxide and limonene, wherein the metal salts treat the acute case of the aforementioned disorder and the limonene is used to treat the chronic case. | 10-09-2008 |
20090004297 | Calcium carbonate compositions for preventing or treating hyperphosphatemia - Compositions and methods for inhibiting gastrointestinal absorption of phosphate in a subject are provided. Such compositions are composed of enteric-coated, sustained-release calcium carbonate, which find application in the prevention or treatment of hyperphosphatemia. | 01-01-2009 |
20090047367 | Pharmaceutical composition for improving anxious behaviors of animals and method for preparing the same - A pharmaceutical composition is disclosed in the present invention, which contains a medical material of | 02-19-2009 |
20090263508 | MICRONUTRIENT SUPPLEMENT WITH CALCIUM, VITAMIN D OR CALCIUM & VITAMIN D COMBINATION FOR PREMENSTRUAL SYNDROME, POSTPARTUM DEPRESSION, DEPRESSION AND PANIC ATTACKS - A bolus dose supplement, foodstuff, beverage and beverage concentrate with calcium and vitamin D for the treatment and prevention of PMS, panic attacks, and postpartum depression. The combination of adequate calcium and vitamin D is provided as a multi-vitamin and mineral supplement. The bolus dose is comprised of 2 main ingredients calcium and vitamin D at 1000-1500 mg of elemental calcium in the form of carbonate or citrate or gluconate or citrate maleate and 400-20,000 I.U. of parent vitamin D | 10-22-2009 |
20100104664 | TREATMENT OF CHRONIC RENAL FAILURE AND OTHER CONDITIONS IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS - The present invention generally concerns the management of age-related diseases in domestic animals. Specifically, the present invention is directed to combination therapies for the treatment of progressive renal diseases (e.g., Chronic Renal Failure) and their accompanying secondary disease states. In a composition aspect, the present invention provides a composition comprising a phosphate binder and another pharmaceutically active ingredient. The other pharmaceutically active ingredient is selected from a group consisting of antihypertensives, calcitrol, vitamin D analogues, lipid restriction products, potassium salts, treatments for anemia and alkalization compounds. | 04-29-2010 |
20100119621 | Process for preparing oral calcium compositions - A process for the preparation of an orally administrable calcium composition comprising the steps of: (i) obtaining a physiologically tolerable particulate calcium compound having a mean particle size in the range of 3 to 40 μm, having a crystalline structure and having a surface area of 0.1 to 1.2 m | 05-13-2010 |
20100173017 | Method of manufacturing skin care cream containing baked shell powder - In a method of manufacturing a skin care cream containing baked shell powder, highly calcium-containing shells such as dead shells or pearls is baked and crushed to fine powder to obtain baked shell powder. Then, the obtained baked shell powder is added to mix with a raw material for manufacturing cosmetic cream. | 07-08-2010 |
20100215776 | METHOD OF TREATING A SORE THROAT - A composition comprising an antacid, and a local, topical anesthetic. The composition is used to relieve pain or discomfort associated with a sore throat, and therefore, the invention is also directed to a method of alleviating the pain or discomfort associated with a sore throat comprising instructing a human to orally administer the composition. | 08-26-2010 |
20100221362 | STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES - Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations. | 09-02-2010 |
20100227006 | POWDER MIX OF POTASSIUM CALCIUM CITRATE FOR THE TREATMENT OF KIDNEY STONES AND OSTEOPOROSIS - A composition comprising a powder mixture of potassium citrate and calcium citrate as mixtures of pure chemical salts and methods of making and using the composition are disclosed. The composition is useful for the treatment and prevention of kidney stones and osteoporosis and better delivers potassium and calcium than commonly used potassium and calcium supplements. | 09-09-2010 |
20100291240 | Method to Stabilize a Dietary Supplement to Facilitate Joint Health in Humans - The present invention provides for compositions comprising glucosamine wherein the glucosamine has improved and/or enhanced stability. Additionally, the present invention provides for methods of stabilizing compositions for use in preparing an oral dosage form comprising glucosamine. | 11-18-2010 |
20100310677 | STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING PHOSPHORYLATED AMINO ACIDS - Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations. | 12-09-2010 |
20100310678 | Compositions and Methods for Nutrition Supplementation - The present invention relates to compositions, that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment, comprise vitamin B | 12-09-2010 |
20100330205 | PHARMACEUTICAL COMPOSITION - A pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. | 12-30-2010 |
20110033558 | POLYMERS PRODUCED BY USING SULPHUR COMPOUNDS IN THE FORM OF TRANSFER AGENTS FOR CONTROLLED RADICAL POLYMERISATION OF ACRYLIC ACID AND THE USE THEREOF - The invention concerns the polymers obtained by the use of sulphur compounds in a process for controlled radical polymerisation in water of acrylic acid and/or acrylic acid with hydrosoluble monomers. It concerns also their uses as dispersant agents or agents to aid grinding and/or co-grinding of mineral matters in aqueous suspensions, and as dispersant agents incorporated directly in aqueous formulations containing mineral matters. Finally, the invention concerns the formulations of mineral matters obtained in this manner. | 02-10-2011 |
20110274771 | Prenatal Syptomatic Kit - A medication kit includes a plurality of individual non-prophylactic, non-urgent care symptomatic treatments configured to treat the symptoms of a pre-existing medical condition such as pregnancy. The treatments include a combination of pharmaceutical treatments and non-pharmaceutical treatments corresponding to particular symptoms often associated with the pre-existing condition. Each of the pharmaceutical treatments are configured for mutually independent dosage, and are predetermined by an authoritative organization such as the Food and Drug Administration to be safe for use at the mutually independent dosages, in combination with one another by otherwise healthy patients having the pre-existing medical condition, without expectation of adverse side effects. | 11-10-2011 |
20120195981 | MICRONUTRIENT SUPPLEMENT WITH CALCIUM, VITAMIN D OR CALCIUM & VITAMIN D COMBINATION FOR PREMENSTRUAL SYNDROME, POSTPARTUM DEPRESSION, DEPRESSION AND PANIC ATTACKS - A bolus dose supplement, foodstuff, beverage and beverage concentrate with calcium and vitamin D for the treatment and prevention of PMS, panic attacks, and postpartum depression. The combination of adequate calcium and vitamin D is provided as a multi-vitamin and mineral supplement. The bolus dose is comprised of 2 main ingredients calcium and vitamin D at 1000-1500 mg of elemental calcium in the form of carbonate or citrate or gluconate or citrate maleate and 400-20,000 I.U. of parent vitamin D | 08-02-2012 |
20120207859 | CALCIUM CARBONATE GRANULATION - Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. | 08-16-2012 |
20120237618 | FORMULATIONS, DEVICES AND METHODS FOR TREATING AND PREVENTING MUCOSITIS - The present invention is directed to compositions, devices, and methods for non-irritatively treating and preventing mucositis, such as chronic rhinosinusitis (CRS). Some aspects of the invention concern compositions comprising or consisting essentially of sodium phosphate buffer (e.g., sodium phosphate dibasic and sodium phosphate monobasic) and calcium carbonate; mucoadministration devices and kits containing such compositions; and methods for treating or preventing mucositis conditions such as CRS, comprising mucoadministering a composition of the invention to a subject in need thereof. | 09-20-2012 |
20130022690 | PHARMACEUTICAL COMPOSITION AND METHOD FOR REDUCING WEIGHT - The present invention relates to a pharmaceutical composition, particularly homeopathic medicines for weight reduction, comprising the following components | 01-24-2013 |
20130122117 | COMPOSITION COMPRISING CRUSTACEAN GASTROLITH COMPONENTS AND ITS USE - Provided is a formulation containing amorphous or microcrystalline calcium carbonate finely interspersed with organic matter in a ratio of 10 parts of the carbonate per 1 to 3 parts of the organic matter, wherein the organic matter consists of chitin and polypeptide. The formulation is efficient in treating various pathological conditions, including proliferative diseases, neurological disorders, and musculoskeletal disorders. | 05-16-2013 |
20130164389 | Calcium Carbonate Granulation - Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. | 06-27-2013 |
20130280347 | PHARMACEUTICAL COMPOSITION AND METHOD FOR REDUCING WEIGHT - A method for weight reduction, involving pharmaceutical compositions, particularly homeopathic medicines for weight reduction, including the following components: | 10-24-2013 |
20140037759 | Antacid Tablet - Aspects of the present invention are directed to an oral antacid tablet comprising at least about 60% by weight directly compressible granulated calcium carbonate and an intense flavoring. The tablet may have a hardness of at least about 22 Strong-Cobb units and the tablet may have a mass of between about 500 mg and about 1,000 mg. Tablets of the present invention reduce or eliminate heartburn symptoms and also freshen breath. | 02-06-2014 |
20140079814 | Method and Composition for Treating Gastro-Esophageal Disorders - An orally administered composition that includes least one alkaline agent with a pH of at least 9.0 to 12.0, mixed in an aqueous vehicle with relatively high surface tension, high viscosity and lateral adhesion properties. When mixed, a low water soluble emulsion is formed that evenly coats and partially adheres to the lower section of the esophagus and the LES and forms a relatively long acting, protective barrier and partially neutralizes gastric acid. In one embodiment, the alkaline agent is potassium hydroxide and the aqueous vehicle is made of hydroxypropyl methyl cellulose, polyethylene glycol or ethylene glycol and additional thickener agents capable of withstanding high pH environments, such as xanthan gum, croscarmellose sodium, and microcrystalline cellulose. Additional organoleptic agents, such as gum Arabic and polyethylene glycol, flavorings, such as sodium chloride, acesulfame potassium, sodium saccharine, and mint, and stabilizers such as colloidal silica made be added. | 03-20-2014 |
20140147521 | BREATH ALCOHOL EQUALIZATION COMPOSITION - There is provided a residual mouth alcohol inhibitor configured as an oral composition that absorbs residual mouth alcohol that remains in the mouth of an individual following the consumption of alcohol. The oral composition comprises a combination of sodium bicarbonate, calcium carbonate, parsley, kelp, fructose, citric acid, natural flavors, artificial flavors, maltodextrin, and silicon dioxide whereby the ratio of sodium bicarbonate to calcium bicarbonate in the composition is approximately 1:1 and the ratio of sodium bicarbonate to parsley in the composition is approximately 2:1 and the ratio of parsley to kelp in the composition is approximately 4:1. | 05-29-2014 |
20150037438 | CHEWABLE GELLED EMULSIONS - An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion. | 02-05-2015 |
20150056306 | AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF CALCIUM MALABSORPTION AND METABOLIC BONE DISORDERS - Provided are methods for treating calcium malabsorption and conditions associated with calcium malabsorption, employing the administration of a composition containing stable amorphous calcium carbonate. Further provided are methods for increasing bone mineral density in a bone metabolism associated disorders, diseases or conditions, employing the administration of said composition in combination with a bone resorption inhibitor. | 02-26-2015 |
20150314004 | FREEZE-DRIED EXCIPIENT AND PREPARATION METHOD THEREOF - A freeze-dried excipient and a preparation method thereof. The freeze-dried excipient only comprises an active ingredient and a binder, and does not comprise a support agent. The weight ratio of the active ingredient to the binder is 1:100 to 100:1. The binder is adhesives, cellulose ethers, modified starches, PVP, carbomer, PVA, hyaluronic acids, albumin, chitosan, dextran, agar, polyamino acid, glycan or a combination thereof. | 11-05-2015 |
20150320790 | Antacid - A low-viscosity, high pH antacid composition comprising: sodium bicarbonate, potassium bicarbonate; calcium carbonate, sweetener, and water. The concentration of sodium bicarbonate in the composition of the invention is preferably in the range of from 1% to 3% by weight. The concentration of potassium bicarbonate in the composition of the invention is preferably in the range of from 0.5% to 1% by weight. The concentration of calcium carbonate in the composition of the invention is preferably in the range of from 0.25% to 1% by weight. The concentration of sweetener in the composition of the invention is preferably in the range of from 0.02% to 0.04% by weight. The remainder of the composition is a low viscosity transport agent, such as water. Additionally, stabilizers may be added and flavoring/coloring agents may be added. | 11-12-2015 |
20150352018 | ENCODED PARTICLES COMPOSITIONS - The present invention provides a composition comprising at least one type of irradiated crystals and an aqueous preparation. The aforementioned irradiated crystals are exposed to a changing electromagnetic field. The present invention further relates to methods and processes for preparing and using the compositions. | 12-10-2015 |
20150366903 | ORALLY-ADMINISTRABLE COMPOSITIONS COMPRISING STABLE AMORPHOUS CALCIUM CARBONATE - The present invention provides orally-administrable compositions comprising stable amorphous calcium carbonate (ACC). The compositions are preferably prepared as solid dosage forms such as tablets, capsules and powders. The present invention further provides methods for supplementing oral calcium intake in subjects and as well as methods for treating osteoporosis, osteomalacia and related diseases. | 12-24-2015 |
20150374747 | AMORPHOUS CALCIUM CARBONATE FOR ACCELERATED BONE GROWTH - The present invention provides a method for accelerating bone growth in a subject having a bone condition, selected from the group consisting of a fracture by external force, pathological fracture, fatigue fracture, distraction osteogenesis, osteotomy, osseointegration and combinations thereof, the method employing the administration of a composition containing stable amorphous calcium carbonate, comprising at least one stabilizer. Further provided are the orally-administrable pharmaceutical compositions for use in accelerating bone growth in said bone conditions. | 12-31-2015 |
20160045546 | STABLE AMORPHOUS CALCIUM CARBONATE COMPRISING SYNTHETIC PHOSPHORYLATED PEPTIDES - Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations. | 02-18-2016 |
20160067180 | SEMI-SOLID CHEWABLE DOSAGE FORM FOR OVER-THE-COUNTER MEDICATIONS AND METHOD FOR PRODUCING SAME - The invention provides a semi-solid chewable dosage form for use as an over-the-counter medication that contains an active pharmaceutical ingredient to treat symptoms associated with allergies, colds, coughs, fever, pain, gastrointestinal disorders, sleep, and other common conditions. The invention further provides a semi-solid chewable dosage form that contains an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention also provides a semi-solid chewable dosage form that contains a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent. | 03-10-2016 |
20160184198 | METHOD OF COUNTERING RESIDUAL MOUTH ALCOHOL - There is provided a residual mouth alcohol inhibitor configured as an oral composition that absorbs residual mouth alcohol that remains in the mouth of an individual following the consumption of alcohol. The oral composition comprises a combination of sodium bicarbonate, calcium carbonate, parsley, kelp, fructose, citric acid, natural flavors, artificial flavors, maltodextrin, and silicon dioxide whereby the ratio of sodium bicarbonate to calcium bicarbonate in the composition is approximately 1:1 and the ratio of sodium bicarbonate to parsley in the composition is approximately 2:1 and the ratio of parsley to kelp in the composition is approximately 4:1. | 06-30-2016 |
20170232036 | Method and Composition for Treating Gastro-Esophageal Disorders | 08-17-2017 |